Srdjan Stankovic

Srdjan Stankovic

No open positions remaining
69 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Srdjan R. Stankovic, MD, is a President at ACADIA Pharmaceuticals, Inc. He is on the Board of Directors at Neurogene, Inc. Dr. Stankovic was previously employed as a SVP-Clinical Development & Medical Affairs by Alkermes Plc, a SVP & Head-Global Clinical Development by Teva Pharmaceuticals USA, Inc., a SVP-Medical Affairs & Clinical Development by Forest Laboratories, Inc., a Chief Development Officer & EVP by Neurogen Corp., a Senior Vice President-Worldwide Clinical Research by Cephalon, Inc., a Vice President-US Clinical Development by Johnson & Johnson Pharmaceutical Research & Development LLC, and a Vice President-US Clinical Development by UCB Pharma, Inc. He received his graduate degree from The University of Alabama and a doctorate degree from the University of Belgrade.

Former positions of Srdjan Stankovic

CompaniesPositionEnd
Director/Board Member 2023-12-28
ACADIA PHARMACEUTICALS INC. President 2022-12-30
ALKERMES PLC Chief Tech/Sci/R&D Officer 2015-10-31
Corporate Officer/Principal 2012-12-31
FOREST LABORATORIES, INC. Corporate Officer/Principal 2010-05-31
See the detail of Srdjan Stankovic's experience

Education of Srdjan Stankovic

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Srdjan Stankovic